Burney Company’s PDL BioPharma, Inc. PDLI Stock Holding History

Burney Company’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,934	Closed	-$44K	–	402
2016 Q2	$44K	Sell	13,934 -3,319	-19%	-$11.1K	﹤0.01%	372
2016 Q1	$57K	Sell	17,253 -1,731	-9%	-$5.4K	﹤0.01%	385
2015 Q4	$71K	Sell	18,984 -346	-2%	-$1.45K	0.01%	370
2015 Q3	$97K	Sell	19,330 -8,306	-30%	-$47.6K	0.01%	366
2015 Q2	$178K	Sell	27,636 -512,866	-95%	-$3.44M	0.01%	388
2015 Q1	$3.8M	Buy	540,502 +44,700	+9%	+$324K	0.26%	111
2014 Q4	$3.82M	Buy	495,802 +49,775	+11%	+$394K	0.3%	101
2014 Q3	$3.33M	Buy	446,027 +53,557	+14%	+$497K	0.29%	100
2014 Q2	$3.8M	Buy	392,470 +97,994	+33%	+$873K	0.33%	94
2014 Q1	$2.45M	Buy	294,476 +80,925	+38%	+$694K	0.22%	121
2013 Q4	$1.8M	Buy	213,551 +56,463	+36%	+$476K	0.18%	147
2013 Q3	$1.25M	Buy	157,088 +91,741	+140%	+$737K	0.14%	173
2013 Q2	$504K	Buy	+65,347	New	+$510K	0.06%	254

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Burney Company's PDLI Position: Q3 2016 in Review

Burney Company sold out of PDL BioPharma, Inc. (PDLI) in Q3 2016, closing a stake of 13,934 shares — an estimated $44K sold.

Burney Company first reported a position in PDLI in Q2 2013 and held it in 13 quarters. The position peaked at $3.82M in Q4 2014. 197 funds tracked by Wall St. Rank hold PDLI as of Q3 2016.

Burney Company reported no remaining PDL BioPharma, Inc. position as of Q3 2016 after selling out during the quarter.
Burney Company sold 13,934 PDL BioPharma, Inc. shares in Q3 2016, an estimated $44K.
Burney Company first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 13 quarters.
Burney Company's PDL BioPharma, Inc. position peaked at $3.82M in Q4 2014.
197 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2016.

Based on Burney Company's 13F filing for Q3 2016, filed 14 Nov 2016.